Overexpression of PRDX2 alleviates chronic thromboembolic pulmonary hypertension by modulating inflammation and mitophagy

Chen Gong, Xiaoyan Lan, Yiming Xie, Xiaobing Wu, Fengxia Wu, Xing Chen, Huilei Zheng, Hong Wen, Feng Huang, Zhiyu Zeng · 2025

Read Overexpression of PRDX2 alleviates chronic thromboembolic pulmonary hypertension by modulating inflammation and mitophagy by Chen Gong, Xiaoyan Lan, Yiming Xie, Xiaobing Wu, Fengxia Wu, Xing Chen, Huilei Zheng, Hong Wen, Feng Huang, Zhiyu Zeng (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12800292.txt.

Description

Chen Gong and co-authors report a 2025 study of a guard enzyme in a lung pressure disease tied to old clots. In this disease, clots scar the lung vessels, pressure climbs, and the heart strains. The enzyme, PRDX2, helps cells keep their chemical balance and calm swelling, but its role here was unclear.

Protein scans of patient blood found the enzyme raised next to healthy controls. A rat model of the disease was built with injected beads. In lung tissue and vessel lining cells, the team raised and lowered the enzyme to watch the effects. Those shifts moved swelling signals and the cell process that clears worn mitochondria, which hints at how the enzyme eases the disease.

Catalog record

CREATORChen Gong, Xiaoyan Lan, Yiming Xie, Xiaobing Wu, Fengxia Wu, Xing Chen, Huilei Zheng, Hong Wen, Feng Huang, Zhiyu Zeng
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE41 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12800292

Browse the full library · About the Tower of Babel